Recombinant viral vector for gene transfer into lymphoid cells

Abstract

A recombinant herpesvirus, a method for producing the recombinant herpesvirus, and a pharmaceutical composition comprising the recombinant herpesvirus, are provided with a method for producing a recombinant herpesvirus using a BAC vector sequence. In addition, a vector comprising a herpesvirus genomic gene and a BAC vector sequence, a cell comprising the vector, and a nucleic acid cassette comprising a fragment, which is capable of homologous recombination with a herpesvirus genome, and a BAC vector sequence, are provided.

1 . A method of treatment, prevention, or therapy of infectious disease comprising:
 infecting a T lymphoid cell with a vector comprising a human herpesvirus genome, comprising an essential gene and a non-essential region and a BAC vector sequence linked to the herpesvirus genome, wherein the BAC vector sequence is inserted into a non-essential region of a herpesvirus genome, and wherein the non-essential region is a non-essential region of HHV-7 or HHV-6.